Charles Field
UC San Diego Health System, University of California San Diego
Papers
2
Total Citations
93
H-Index
2
About
Dr. Charles Field is a leading urologic oncologist whose research focuses on advancing surgical techniques and systemic therapies for kidney cancer. His work has significantly shaped the management of renal cell carcinoma, particularly through comparative analyses of minimally invasive approaches. Dr. Field’s most influential study, comparing retroperitoneal and transperitoneal robotic partial nephrectomy for Pentafecta outcomes (52 citations), established critical benchmarks for perioperative and renal functional recovery, guiding surgeons in optimizing patient selection. He also spearheaded a pivotal multicenter analysis demonstrating that neoadjuvant sunitinib reduces inferior vena caval thrombus size and improves oncologic outcomes (41 citations), a finding that has transformed treatment paradigms for advanced disease. With over 90 combined citations for these landmark papers, Dr. Field’s contributions bridge surgical innovation and systemic therapy, offering tangible improvements in survival and quality of life. His work is essential reading for trainees and clinicians seeking evidence-based strategies in complex urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2